These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2113135)

  • 1. [Clinical significance of the second component of complement assay].
    Takemura S
    Nihon Rinsho; 1990 Feb; 48 Suppl():647-9. PubMed ID: 2113135
    [No Abstract]   [Full Text] [Related]  

  • 2. Determination of the second component of complement (C2) by electroimmunoassay in sera from patients with systemic lupus erythematosus.
    Ueda A; Kusaba T; Yanase T
    Clin Exp Immunol; 1983 Jul; 53(1):217-24. PubMed ID: 6409476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited deficiency of the second component of complement. Rheumatic disease associations.
    Glass D; Raum D; Gibson D; Stillman JS; Schur PH
    J Clin Invest; 1976 Oct; 58(4):853-61. PubMed ID: 965492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of hemolytic complement activity via classical pathway].
    Takemura S; Kondo M
    Nihon Rinsho; 1990 Feb; 48 Suppl():634-6. PubMed ID: 2355588
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical significance of the fourth component of complement assay].
    Takemura S; Kondo M
    Nihon Rinsho; 1990 Feb; 48 Suppl():654-6. PubMed ID: 2113136
    [No Abstract]   [Full Text] [Related]  

  • 6. Deficiency of C2, the second complement component, in the family of a patient with SLE-like syndrome: the first case of hereditary C2 deficiency in Czechoslovakia.
    Starsia Z; Zitnan D; Loos M; Stefanovic J; Bosák V; Niks M; Tomanová H; Lukác J; Lulovicová M
    Haematologia (Budap); 1987; 20(4):215-20. PubMed ID: 3428724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [C4(beta1E globulin) and C2].
    Kitamura H
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():86-9. PubMed ID: 20942008
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of systemic lupus erythematosus and SLE-like syndromes with hereditary and acquired complement deficiency states.
    Agnello V
    Arthritis Rheum; 1978 Jun; 21(5 Suppl):S146-52. PubMed ID: 666879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lupus and protein deficiencies of the classical complement pathway].
    Weiss L; Maillet F; Kazatchkine M
    Rev Prat; 1990 Sep; 40(21):1937-40. PubMed ID: 2237185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the component and regulatory proteins of the classical pathway C3 convertase.
    Welch TR; Forristal J; Beischel L
    J Lab Clin Med; 1986 Jun; 107(6):529-33. PubMed ID: 3635565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunoglobulins and complement in systemic lupus erythematosus, rheumatoid arthritis and juvenile rheumatoid arthritis].
    Dostal Ts; Shusta A; Gana I; Bardfeld R
    Ter Arkh; 1974; 46(11):98-100. PubMed ID: 4216106
    [No Abstract]   [Full Text] [Related]  

  • 13. [The complement system].
    Lambert PH
    Schweiz Med Wochenschr; 1975 Sep; 105(37):1180-4. PubMed ID: 1215899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the alternative complement pathway in systemic lupus erythematosus.
    Wilson MR; Arroyave CM; Nakamura RM; Vaughan JH; Tan EM
    Clin Exp Immunol; 1976 Oct; 26(1):11-20. PubMed ID: 826360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complement: physiopathology, pharmacology and clinical aspects].
    Orrico A; Auteri A
    Ann Sclavo Collana Monogr; 1985; 2(1-2):3-146. PubMed ID: 3880494
    [No Abstract]   [Full Text] [Related]  

  • 16. Decreased levels of complement components C4 and C2 in lupus erythematosus: genetic defect or complement activation?
    Hauptmann G; Uring-Lambert B; Kazatchkine M; Voigtländer V; Bahmer F; Seligmann M
    Diagn Immunol; 1984; 2(1):63-4. PubMed ID: 6499374
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunologic tests: C2].
    Kitano E; Kitamura H
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():59-62. PubMed ID: 16111188
    [No Abstract]   [Full Text] [Related]  

  • 18. [Disseminated lupus erythematosus and hereditary C2 deficiency].
    Dantant M; Godin M; Rivat C; Dubois D; Gilbert D; Fontaine M; Cavelier B; Fillastre JP
    J Urol Nephrol (Paris); 1978; 84(4-5):347-9. PubMed ID: 308105
    [No Abstract]   [Full Text] [Related]  

  • 19. [Systemic lupus erythematosus associated with homozygous C2 deficiency. Apropos of a case report and literature review].
    Borradori L; Gueissaz F; Frenk E; Rohner R; Scherz R; Lantin JP; Späth PJ
    Schweiz Med Wochenschr; 1991 Mar; 121(12):418-23. PubMed ID: 2028245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quantitative determination of the 3d component of the complement in human sera].
    Bragiel I; Skowrońska H
    Acta Haematol Pol; 1974; 5(2):145-52. PubMed ID: 4134126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.